All news

Kaplan Fox probes Cellebrite over securities law violations

Alpha Vantage · The National Law Review · · AI-summarised by FinFlash

Kaplan Fox & Kilsheimer LLP is investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for potential securities law violations after the stock fell 29%. The probe follows Cellebrite's August 13, 2026 second-quarter report, which missed Annual Recurring Revenue projections, cut full-year guidance and included an abrupt CEO change. The firm seeks investors who suffered losses.

Read original source

CLBT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.